Banned scientist now at Schering-Plough

A scientist that the University of Washington found guilty of research misconduct is now an employee of the pharmaceutical company, linkurl:Schering-Plough.;http://www.sch-plough.com In an Email to __The Scientist__, a company spokesperson, Stephen Galpin, confirmed that Scott Brodie, a former UW researcher, "is a current employee and that we recently became aware of the University of Washington investigation." The university's investigation into Brodie's work found 15 instances of faked data,

Written byKerry Grens
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
A scientist that the University of Washington found guilty of research misconduct is now an employee of the pharmaceutical company, linkurl:Schering-Plough.;http://www.sch-plough.com In an Email to __The Scientist__, a company spokesperson, Stephen Galpin, confirmed that Scott Brodie, a former UW researcher, "is a current employee and that we recently became aware of the University of Washington investigation." The university's investigation into Brodie's work found 15 instances of faked data, and the school banned Brodie from working there. Brodie sued the school and the __Seattle Times__ to prevent them from disclosing the investigation's report. As we linkurl:reported;http://www.the-scientist.com/blog/display/53931/ earlier, he lost the case. While searching in the Thomson ISI database for publications Brodie produced while at UW, I noticed that a Scott Brodie had published papers on linkurl:interleukins;http://iai.asm.org/cgi/content/abstract/74/11/6092 in the last two years. I don't know whether Schering-Plough was already aware of Brodie's past at the time of my query. Galpin wrote in his Email, "As this is a personnel matter, we cannot comment further."
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile
Share
Image of a woman with her hands across her stomach. She has a look of discomfort on her face. There is a blown up image of her stomach next to her and it has colorful butterflies and gut bacteria all swarming within the gut.
November 2025, Issue 1

Why Do We Feel Butterflies in the Stomach?

These fluttering sensations are the brain’s reaction to certain emotions, which can be amplified or soothed by the gut’s own “bugs".

View this Issue
Olga Anczukow and Ryan Englander discuss how transcriptome splicing affects immune system function in lung cancer.

Long-Read RNA Sequencing Reveals a Regulatory Role for Splicing in Immunotherapy Responses

Pacific Biosciences logo
Research Roundtable: The Evolving World of Spatial Biology

Research Roundtable: The Evolving World of Spatial Biology

Conceptual cartoon image of gene editing technology

Exploring the State of the Art in Gene Editing Techniques

Bio-Rad
Conceptual image of a doctor holding a brain puzzle, representing Alzheimer's disease diagnosis.

Simplifying Early Alzheimer’s Disease Diagnosis with Blood Testing

fujirebio logo

Products

Eppendorf Logo

Research on rewiring neural circuit in fruit flies wins 2025 Eppendorf & Science Prize

Evident Logo

EVIDENT's New FLUOVIEW FV5000 Redefines the Boundaries of Confocal and Multiphoton Imaging

Evident Logo

EVIDENT Launches Sixth Annual Image of the Year Contest

10x Genomics Logo

10x Genomics Launches the Next Generation of Chromium Flex to Empower Scientists to Massively Scale Single Cell Research